Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Assets Average (2020 - 2022)

Atea Pharmaceuticals has reported Assets Average over the past 3 years, most recently at $690.5 million for Q3 2022.

  • Quarterly results put Assets Average at $690.5 million for Q3 2022, down 19.48% from a year ago — trailing twelve months through Sep 2022 was $690.5 million (down 19.48% YoY), and the annual figure for FY2021 was $818.3 million, changed.
  • Assets Average for Q3 2022 was $690.5 million at Atea Pharmaceuticals, down from $705.8 million in the prior quarter.
  • Over the last five years, Assets Average for AVIR hit a ceiling of $857.5 million in Q3 2021 and a floor of $486.9 million in Q4 2020.
  • Median Assets Average over the past 3 years was $776.6 million (2021), compared with a mean of $750.3 million.
  • Biggest five-year swings in Assets Average: surged 66.0% in 2021 and later dropped 19.48% in 2022.
  • Atea Pharmaceuticals' Assets Average stood at $486.9 million in 2020, then surged by 66.0% to $808.2 million in 2021, then fell by 14.57% to $690.5 million in 2022.
  • The last three reported values for Assets Average were $690.5 million (Q3 2022), $705.8 million (Q2 2022), and $745.0 million (Q1 2022) per Business Quant data.